Cogstate Ltd Expands Brain Health Assessment Innovations
Company Announcements

Cogstate Ltd Expands Brain Health Assessment Innovations

Cogstate Ltd (AU:CGS) has released an update.

Cogstate Ltd, a leader in neuroscience technology, continues to enhance brain health assessments through cutting-edge cognitive testing and eCOA solutions. The company has partnered with Eisai to expand its digital cognitive assessments in the USA and Asia, aiming to streamline clinical trials and improve patient care. With over 20 years of experience, Cogstate remains committed to supporting biopharmaceutical research and clinical care globally.

For further insights into AU:CGS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskCogstate Director Receives New Performance Rights
TipRanks Australian Auto-Generated NewsdeskCogstate Ltd Issues New Performance Rights
TipRanks Australian Auto-Generated NewsdeskCogstate Partners with Medidata for Strategic Growth
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App